ARB Slows Cognitive Decline in Trial... But How?

(MedPage Today) -- The angiotensin receptor blocker (ARB) candesartan had cognitive benefits that were likely independent of the drug's blood pressure (BP)-lowering effect, a small randomized trial indicated.
People randomized to candesartan instead...